Journal Review Series: April-June 2019
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019.
It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat …
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019.
It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat … 
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients. In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies.
[caption id="attachment_8301" align="alignleft" width="612"] Click image to en … 
This month’s Patient Buzz includes several articles about celebrities who are going public with their skin conditions. From melanoma to psoriatic arthritis to eczema, more patients may seek treatment because of the awareness celebrities are bringing to these conditions.
Be prepared for your patients’ questions by perusing these dermatology articles from the consumer press:
Allure: ASDS … 
JDD Podcast Recap and Author Interview
Podcast host Dr. Adam Friedman sat down with Dr. David Rosmarin, Assistant Professor of Dermatology and Residency Program Director at Tufts University School of Medicine, to dive into what he learned from performing a retrospective chart review and how his work and his experience guides his clinical decision making when managing psoriasis. Here are the high … 
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be …